HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Partial amino acid sequence of a novel 40-kDa human aortic protein, with vitronectin-like, fibrinogen-like, and calcium binding domains: aortic aneurysm-associated protein-40 (AAAP-40) [human MAGP-3, proposed].

Abstract
A microfibrillar protein (40 kDa) purified from the adventitia of the human abdominal aorta is immunoreactive with IgG harvested from the wall of abdominal aortic aneurysms. We have partially sequenced this protein and found that it has fibrinogen alpha-, beta-, and gamma-like domains, a vitronectin-like domain, and a possible site for binding calcium. Because of homologies with other microfibril-associated glycoproteins and because it is the third member of the family to be characterized in man, we suggest the name MAGP-3.
AuthorsS Xia, K Ozsvath, H Hirose, M D Tilson
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 219 Issue 1 Pg. 36-9 (Feb 06 1996) ISSN: 0006-291X [Print] United States
PMID8619823 (Publication Type: Journal Article)
Chemical References
  • Calcium-Binding Proteins
  • Contractile Proteins
  • Extracellular Matrix Proteins
  • Immunoglobulin G
  • RNA Splicing Factors
  • Vitronectin
  • microfibrillar protein
  • Fibrinogen
  • Calcium
Topics
  • Amino Acid Sequence
  • Animals
  • Aorta, Abdominal (metabolism)
  • Aortic Aneurysm, Abdominal (metabolism)
  • Binding Sites
  • Calcium (metabolism)
  • Calcium-Binding Proteins (chemistry, isolation & purification)
  • Cattle
  • Conserved Sequence
  • Contractile Proteins (chemistry, isolation & purification)
  • Extracellular Matrix Proteins
  • Fibrinogen (chemistry)
  • Humans
  • Immunoglobulin G
  • Molecular Sequence Data
  • Molecular Weight
  • Muscle, Smooth, Vascular (metabolism)
  • RNA Splicing Factors
  • Sequence Homology, Amino Acid
  • Vitronectin (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: